Enzo Biochem - Comparative Multiple Analysis

Enzo Biochem (Comparative Multiple Analysis)

placeholder_large_analysis.png
Banner%20-%20The%20perfect%20tool%20for%20investors%281%29.gif

Notes on the Comparative Multiple Analysis of Enzo Biochem

WikiWealth compares Enzo Biochem's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Enzo Biochem's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Enzo Biochem.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Enzo Biochem's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Enzo Biochem's Analysis


How does this work? The Comparative Investment Analysis determines the value of Enzo Biochem by comparing Enzo Biochem financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Enzo Biochem.

See the Enzo Biochem cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Enzo Biochem.

Also, see the Enzo Biochem's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Enzo Biochem's valuation conclusion for a quick summary.